prevalence
Study 03 · Epidemiology

Hair loss, by the numbers.

It is one of the most common human experiences and one of the least discussed. Up to four in five men and one in two women will see pattern hair loss in their lifetime. Here is when it starts, how it differs by sex, and how well the standard treatments actually perform.

By aichabelleUpdated 3 June 2026Reproduce under CC BY 4.0

Pattern hair loss — androgenetic alopecia — is the most common cause of hair loss in both men and women. It accounts for roughly 95% of male hair loss. Across a lifetime, up to 80% of men and as many as 50% of women are affected to some degree. It is hereditary, hormone-mediated, and progressive — and for most people it begins far earlier than they expect.

The mean age of onset is 23.9 years in men and 29.5 years in women. About a quarter of affected men begin before they turn 21. By 35, more than 65% of men show visible loss; by 50, around 85% have meaningful thinning. For women, the curve climbs later and is closely tied to menopause.

80%
of men face pattern hair loss in their lifetime (up to 50% of women).
23.9
mean age of onset in men; 29.5 years in women.
95%
of male hair loss is androgenetic (pattern) alopecia.
Figure 1

Pattern hair loss rises with age

Share of men showing meaningful pattern hair loss by age band, with the female curve for comparison.

MenWomen
0%25%50%75%100% 25%65%85%53%* 40%37%* Age 21Age 35Age 50Age 65 *by age 65, ~53% of men and 37% of women report baldness (different measure)
Chart © aichabelle · CC BY 4.0 Source: NCOA, Medihair, PLOS One / All of Us study
Embed this chart
Figure 2

Lifetime risk, and how early it begins

Share affected over a lifetime, and the mean age at which pattern hair loss first appears.

Lifetime risk 80% 50% Men Women Mean age of onset 23.9 years · men 29.5 years · women
Chart © aichabelle · CC BY 4.0 Source: J. Cosmetic Dermatology, 2025, MedlinePlus Genetics
Embed this chart
What works

The treatment numbers.

The two licensed mainstays are topical minoxidil and oral finasteride. Reported improvement rates vary widely by study and endpoint, but a clear order emerges: minoxidil alone is the weakest, finasteride stronger, and the two combined the most effective. No topical reverses the genetics — they slow and partly recover the loss.

Figure 3

Reported improvement, by treatment

Share of men showing improvement in androgenetic alopecia. Figures span monotherapy and combination studies; ranges, not guarantees.

Minoxidil alone <40% Finasteride 80.5% Combination >92% 0%100%
Chart © aichabelle · CC BY 4.0 Source: British Journal of Dermatology, 2025, Bayesian network meta-analysis, PMC
Embed this chart
Method

How we read it.

Prevalence and onset figures are drawn from epidemiological reviews and a large US cross-sectional study (the NIH All of Us cohort), plus dermatology summaries. Prevalence depends heavily on population and grading scale — figures differ between ethnic groups and measurement methods — so we report the widely-cited ranges and link each source. Treatment improvement rates are study-specific and not directly comparable; we present them as a directional ranking, not head-to-head trial results. These are population statistics, not medical advice. Hair loss can have many causes; anyone concerned should see a clinician.

Cite this study

aichabelle (2026). Hair loss by the numbers: global statistics on pattern hair loss. The Aichabelle Research Index. aichabelle.com/pages/research-hair-loss

Licence

Original charts © aichabelle, CC BY 4.0. Reproduce with attribution and a link to this page. Underlying figures © their named sources.
From the cabinet & the salon

For hair, we work from the forest and the chair.

Silvavita is our botanical hair active, sourced under named partnership. And at the Willenhall salon, Aicha cares for hair of every texture — by appointment, never rushed.

See Silvavita Book the salon